Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Taipei Medical University Affiliated Hospitals / 臺北醫學大學附屬醫院
  3. Taipei Medical University Hospital / 附設醫院
  4. 健康小百科
  5. 北醫藥訊
  6. 北醫藥訊第一百零五期
 
  • Details
Options

北醫藥訊第一百零五期

Type
other
Date Issued
2024-07-01
Author(s)
臺北醫學大學附設醫院藥劑部
Subjects
臺北醫學大學附設醫院
健康小百科
北醫藥訊
Abstract
治療流感的新選擇- Xofluza®紓伏效膜衣錠 / 陳冠安 藥師
呼吸道融合病毒疫苗介紹─ Arexvy®欣剋融呼吸道融合病毒疫苗 / 盧鈺涵 藥師
新藥介紹 Vocabria® +Rekmbys® /王力民 藥師
URI
https://203.71.86.71/handle/123456789/66595
File(s)
Loading...
Thumbnail Image
Name

105(1).pdf

Size

2.43 MB

Format

Adobe PDF

Checksum

(MD5):4ad76ff4d7823624ec631c2e8497c1a9

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback